Kite Lake Capital Management (UK)’s Array Biopharma Inc ARRY Stock Holding History

Kite Lake Capital Management (UK)’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-867,600	Closed	-$40.2M	–	8
2019 Q2	$40.2M	Buy	+867,600	New	+$24.4M	11.63%	3

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Kite Lake Capital Management (UK)'s ARRY Position: Q3 2019 in Review

Kite Lake Capital Management (UK) sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 867,600 shares — an estimated $40.2M sold.

Kite Lake Capital Management (UK) first reported a position in ARRY in Q2 2019 and held it in 1 quarter. The position peaked at $40.2M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Kite Lake Capital Management (UK) reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Kite Lake Capital Management (UK) sold 867,600 Array Biopharma Inc shares in Q3 2019, an estimated $40.2M.
Kite Lake Capital Management (UK) first reported a position in Array Biopharma Inc in Q2 2019 and held it in 1 quarter.
Kite Lake Capital Management (UK)'s Array Biopharma Inc position peaked at $40.2M in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Kite Lake Capital Management (UK)'s 13F filing for Q3 2019, filed 14 Nov 2019.